Showing results (1841-1850 of 2,081) with videos related to

Sort By:
Pageof 209
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
Cell Reports. Medicine|May 4, 2024
Targeting low levels of MIF expression as a potential therapeutic strategy for ALSLeenor Alfahel, Thomas Gschwendtberger, Velina Kozareva, et al.
Angewandte Chemie (International Ed. in English)|September 13, 2014
A CXCR4-targeted site-specific antibody-drug conjugateSumith A Kularatne, Vishal Deshmukh, Jennifer Ma, et al.
American Journal of Hematology|September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphomaThomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Chromosomal instability determines taxane responseCharles Swanton, Barbara Nicke, Marion Schuett, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphomaNadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
Nature Methods|March 14, 2007
Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studiesRalf Kittler, Vineeth Surendranath, Anne-Kristin Heninger, et al.
British Journal of Haematology|May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American studyAngelo Fama, Jinhua Xiang, Brian K Link, et al.
Hematological Oncology|August 28, 2021
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg typeRobert M Kraft, Stephen M Ansell, Jose C Villasboas, et al.
Pageof 209